VYNE Therapeutics
VYNE
VYNE
55 hedge funds and large institutions have $64.3M invested in VYNE Therapeutics in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 19 increasing their positions, 20 reducing their positions, and 5 closing their positions.
Holders
55
Holders Change
–
Holders Change %
0%
% of All Funds
1.09%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
19
Reduced
20
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AIP
51
Ameritas Investment Partners
Lincoln,
Nebraska
| $3K | 543 | – | – |
|
52
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $2K | 276 | – | – |
|
|
TRCT
53
Tower Research Capital (TRC)
New York
| $1K | 254 | -4,769 | -95% |
|
|
O
54
OrbiMed
New York
| – | – | -662,600 | Closed |
|
|
DM
55
Deerfield Management
New York
| – | – | -99,622 | Closed |
|
|
OAM
56
Oxford Asset Management
Oxford,
United Kingdom
| – | – | -46,796 | Closed |
|
57
Victory Capital Management
San Antonio,
Texas
| – | – | -1,659 | Closed |
|
|
WT
58
Whittier Trust
South Pasadena,
California
| – | – | -700 | Closed |
|
|
CFGS
59
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
OSAM
60
O'Shaughnessy Asset Management
Stamford,
Connecticut
| $0 | 1 | +1 | New |
|
|
VCM
61
Versant Capital Management
Phoenix,
Arizona
| $0 | 57 | +57 | New |
|